Article
Functional orthogonality of WRN inhibitor resistance enables alternating therapy and mutation-tolerant inhibitor design in MSI-H cancers
2026-06-12
Abstract excerpt
Werner syndrome helicase (WRN) is a synthetic-lethal vulnerability in microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) cancers 1–5 , and non-covalent and covalent WRN inhibitors are now entering clinical development 6–9 . A central unresolved question is whether resistance to one WRN inhibitor class inevitably compromises the target, or instead creates actionable vulnerabilities to an alt...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1dc596c8-efb7-5fff-938e-8f3fea65166c
- DOI
- 10.64898/2026.06.09.731233
